What it is: A five-amino-acid synthetic peptide that stimulates the pituitary gland to release growth hormone in natural pulses without meaningfully raising cortisol or prolactin.
Research suggests: Human studies confirm GH stimulation with a selective profile that avoids the cortisol and prolactin elevation seen with older compounds in the same class.
Best for: Growth hormone and sleep quality researchers
Key thing to know: Frequently studied in combination with CJC-1295, which works through a complementary pathway to produce additive GH effects.
What is Ipamorelin?
Ipamorelin is a synthetic pentapeptide (five amino acids) in a class called growth hormone secretagogues (GHS). Unlike synthetic growth hormone, it doesn't introduce external GH; instead, it stimulates the pituitary to release the body's own GH in a pulsatile pattern resembling natural secretion rhythms.
Researchers have studied ipamorelin for its potential role in body composition improvement, recovery enhancement, sleep quality, and the broader effects of optimized growth hormone levels, including its impact on IGF-1 production in the liver. It is notable among GH secretagogues for its selectivity profile, which is consistently highlighted in the research literature.
How it works.
In research, the proposed mechanism has several parts.
Ghrelin receptor: Ipamorelin binds the ghrelin receptor, also called the growth hormone secretagogue receptor (GHS-R), primarily in the pituitary. Activating it triggers a pulse of growth hormone release. GH then travels to the liver and other tissues to stimulate IGF-1 (insulin-like growth factor 1), which mediates many of GH's downstream effects on muscle, fat metabolism, and cellular repair.
What distinguishes it: What sets ipamorelin apart from older GH secretagogues like GHRP-2 and GHRP-6 is its selectivity. Research indicates it produces GH pulses without meaningfully raising cortisol or prolactin, two hormones those older compounds stimulated. Think of it as a precise knock on the pituitary's door to release GH, without triggering the broader stress-hormone cascade.
In combination: Ipamorelin is frequently studied in combination with CJC-1295, a GHRH analogue that works through a different but complementary pathway. Together, research suggests they produce both a sustained elevation of baseline GH and a discrete pulsatile release, an approach studied for additive effects on GH activity.
What the research shows.
The research evidence breaks down as follows.
Human studies: Human studies on ipamorelin confirm it produces meaningful growth hormone pulses with a favorable selectivity profile. Its ability to stimulate GH release without significantly elevating cortisol or prolactin has been demonstrated in clinical pharmacology studies, distinguishing it from less selective compounds in the GHS class.
The evidence gap: However, large long-term randomized controlled trials examining clinical outcomes in general healthy populations are limited. Much of the human research focuses on specific populations, older adults, post-surgical recovery, or short-term pharmacokinetic studies. The long-term safety and efficacy data that exists for approved GH therapies has not been replicated for ipamorelin at the same scale.
Evidence level: The evidence is sufficient to establish the mechanism and acute GH response, but insufficient to make strong claims about long-term outcomes. Research that does exist is generally consistent with the mechanistic model. This is Moderate evidence, human data exists confirming the primary mechanism, but large outcome-focused trials are limited.
Biomarkers to review first.
Research protocols for ipamorelin typically reference the following biomarkers as baseline context. Testing these before exploring this peptide gives you and your healthcare provider the most relevant starting information.
See the full lab testing guide →What it's commonly researched with.
Ipamorelin is most frequently studied in combination with GHRH analogues, where the two compounds act on complementary pathways to produce additive effects on GH output. The combinations below reflect what appears in the research literature, not recommendations for use without clinical supervision.
Goals & biomarkers connected to this peptide.
Go deeper
A research overview of the baseline biomarkers used to establish context before exploring peptide research, viewed through a longevity lens.
Read Research →